A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
暂无分享，去创建一个
R. Stratta | R. Alloway | A. Lo | E. Hodge
[1] R. Stratta,et al. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study1 , 2003, Transplantation.
[2] S. Takemoto. HLA matching in the new millennium. , 2003, Clinical transplants.